Cargando…
Nanostructured SL9-CpG Lipovaccines Elicit Immune Response for the Treatment of Melanoma
Antigen peptides and adjuvants have been extensively investigated for cancer immunotherapy, and they are expected to elicit specific immune responses for cancer treatment. However, the anti-cancer efficacy of antigen peptide and adjuvant-based cancer vaccines has been limited due to the inefficient...
Autores principales: | Mu, Li-Min, Liu, Lei, Liu, Rui, Du, Ya-Fei, Luo, Qian, Xu, Jia-Rui, Xie, Ying, Lu, Wan-Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6539931/ https://www.ncbi.nlm.nih.gov/pubmed/31060324 http://dx.doi.org/10.3390/ijms20092207 |
Ejemplares similares
-
THE STERILIZATION OF LIPOVACCINES
por: Lewis, Paula A., et al.
Publicado: (1920) -
An Experimental Investigation of Lipovaccines, with a Note on Triple Dysentery Lipovaccines
Publicado: (1918) -
Delivery System of CpG Oligodeoxynucleotides through Eliciting an Effective T cell Immune Response against Melanoma in Mice
por: Sun, Wei, et al.
Publicado: (2016) -
PIKfyve Regulates the Endosomal Localization of CpG Oligodeoxynucleotides to Elicit TLR9-Dependent Cellular Responses
por: Hazeki, Kaoru, et al.
Publicado: (2013) -
Preservation of methylated CpG dinucleotides in human CpG islands
por: Panchin, Alexander Y., et al.
Publicado: (2016)